XML 15 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Interim Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Income Statement [Abstract]    
Research and development expenses, net $ 383 $ 184
General and administrative expenses 1,132 1,049
Operating loss (1,515) (1,233)
Financing income (expenses), net 46 (74)
Net loss $ (1,469) $ (1,307)
Net loss per share, basic and diluted $ 0.03 $ 0.04
Weighted-average number of common shares outstanding, basic and diluted 41,453,603 27,212,149